Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherWages, Salaries and Other
Ratios

Spero Therapeutics (SPRO) Other Gross PP&E Adjustments (2016 - 2025)

Spero Therapeutics' Other Gross PP&E Adjustments history spans 10 years, with the latest figure at -$2.1 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 25.46% year-over-year to -$2.1 million; the TTM value through Dec 2025 reached -$2.1 million, down 25.46%, while the annual FY2025 figure was -$2.1 million, 25.46% down from the prior year.
  • Other Gross PP&E Adjustments reached -$2.1 million in Q4 2025 per SPRO's latest filing, down from -$2.1 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$1.2 million in Q4 2023 to a low of -$8.5 million in Q1 2021.
  • Average Other Gross PP&E Adjustments over 5 years is -$4.8 million, with a median of -$4.6 million recorded in 2024.
  • Peak YoY movement for Other Gross PP&E Adjustments: plummeted 55.8% in 2021, then skyrocketed 47.48% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$3.5 million in 2021, then surged by 37.73% to -$2.2 million in 2022, then skyrocketed by 43.5% to -$1.2 million in 2023, then crashed by 36.2% to -$1.7 million in 2024, then dropped by 25.46% to -$2.1 million in 2025.
  • Per Business Quant, the three most recent readings for SPRO's Other Gross PP&E Adjustments are -$2.1 million (Q4 2025), -$2.1 million (Q3 2025), and -$3.5 million (Q2 2025).